1 |
Ailawadi M, Del Priore G (2001). A comparison of thromboembolic prophylaxis in gynecologic oncology patients. Int J Gynecol Cancer, 11, 354-8.
DOI
|
2 |
Clarke-Pearson DL, DeLong ER, Synan IS, et al (1987). Variables associated with postoperative deep venous thrombosis: a prospective study of 411 gynecology patients and creation of a prognostic model. Obstet Gynecol, 69, 146-50.
|
3 |
Committee on Practice Bulletins-Gynecology, American College of Obstetricians and Gynecologists (2007). ACOG practice bulletin no. 84: prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol, 110, 429-40.
DOI
|
4 |
Del Carmen MG, Birrer M, Schorge JO (2012). Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol, 126, 481-90.
DOI
|
5 |
Donati MB (1995). Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice. Thromb Haemost, 74, 278-81.
|
6 |
Diaz ES, Walts AE, Karlan BY, et al (2013). Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival. Gynecol Oncol, 131, 541-5.
DOI
|
7 |
Geerts WH, Pineo GF, Heit JA, et al (2004). Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest, 126, 338-400.
DOI
ScienceOn
|
8 |
Heidrich H, Konau E, Hesse P (2009). Asymptomatic venous thrombosis in cancer patients--a problem often overlooked. Results of a retrospective and prospective study. Vasa, 38, 160-6.
DOI
|
9 |
Heit JA, Mohr DN, Silverstein MD, et al (2000). Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med, 160, 761-8.
DOI
|
10 |
Heit JA, O'Fallon WM, Petterson TM, et al (2002). Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med, 162, 1245-8.
DOI
|
11 |
Kanchanabat B, Stapanavatr W, Meknavin S, et al (2011). Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis. Br J Surg, 98, 1356-64.
DOI
|
12 |
Kunpalin Y, Triratanachat S, Tantbirojn P (2014). Proportion of ovarian cancers in overall ovarian masses in Thailand. Asian Pac J Cancer Prev, 15, 7929-34.
DOI
|
13 |
Lyman GH, Khorana AA, Kuderer NM, et al (2013). American society of clinical oncology clinical practice. venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol, 31, 2189-204.
DOI
|
14 |
Martino MA, Williamson E, Rajaram L, et al (2007). Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosis. Gynecol Oncol, 106, 439-45.
DOI
|
15 |
Matsuo K, Yessaian AA, Lin YG, et al (2013). Predictive model of venous thromboembolism in endometrial cancer. Gynecol Oncol, 128, 544-51.
DOI
|
16 |
Oranratanaphan S, Khemapech N (2013). Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution. Asian Pac J Cancer Prev, 14, 4693-7.
DOI
ScienceOn
|
17 |
Matsuura Y, Robertson G, Marsden DE, et al (2007). Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol, 104, 406-10
DOI
|
18 |
Merkow RP, Bilimoria KY, McCarter MD, et al (2011). Postdischarge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg, 254, 131-7.
DOI
|
19 |
Montoya TI, Leclaire EL, Oakley SH, et al (2014). Fellows' pelvic research network of the society of gynecologic surgeons. venous thromboembolism in women undergoing pelvic reconstructive surgery with mechanical prophylaxis alone. Int Urogynecol J, 25, 921-6.
DOI
|
20 |
Peedicayil A, Weaver A, Li X, et al (2011). Incidence and timing of venous thromboembolism after surgery for gynecological cancer. Gynecol Oncol, 121, 64-9.
DOI
|
21 |
Prandoni P, Falanga A, Piccioli A (2005). Cancer and venous thromboembolism. Lancet Oncol, 6, 401-10.
DOI
|
22 |
Prandoni P, Lensing AW, Piccioli A, et al (2002). Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood, 100, 3484-8.
DOI
|
23 |
Pruemer J (2005). Prevalence, causes, and impact of cancerassociated thrombosis. Am J Health Syst Pharm, 62, 4-6.
|
24 |
Ramirez PT, Nick AM, Frumovitz M, Schmeler KM (2013). Venous thromboembolic events in minimally invasive gynecologic surgery. J minim Invasive Gynecol, 20, 766-9.
DOI
|
25 |
Sandhu R, Pan CX, Wun T, et al (2010). The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. Cancer, 116, 2596-603.
|
26 |
Rickles FR, Edwards RL (1983). Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood, 62, 14-31.
|
27 |
Rodriguez AO, Gonik AM, Zhou H, et al (2011). Venous thromboembolism in uterine cancer. Int J Gynecol Cancer, 21, 870-6.
DOI
|
28 |
Rodriguez AO, Wun T, Chew H, et al (2007). Venous thromboembolism in ovarian cancer. Gynocol Oncol, 105, 784-90.
DOI
|
29 |
Satoh T, Oki A, Uno K, et al (2007). High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer, 97, 1053-7.
DOI
|
30 |
Streiff MB (2015). Predicting the risk of recurrent venous thromboembolism (VTE). J Thromb Thrombolysis, 39, 353-66.
DOI
|
31 |
Young A, Chapman O, Connor C, et al (2012). Thrombosis and cancer. Nat Rev Clin Oncol, 9, 437-49.
DOI
|
32 |
van den Berg YW, Osanto S, Reitsma PH, et al (2012). The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood, 119, 924-32
DOI
ScienceOn
|
33 |
Zwicker JI, Liebman HA, Neuberg D, et al (2009). Tumorderived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res, 15, 6830-40.
DOI
|